REDUCTION IN HEPATIC IRON STORES WITH THE ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) IN PATIENTS (PTS) WITH TRANSFUSION DEPENDENT THALASSEMIA (HBT) AND SICKLE-CELL DISEASE (SCD)
D. Matsui et al., REDUCTION IN HEPATIC IRON STORES WITH THE ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) IN PATIENTS (PTS) WITH TRANSFUSION DEPENDENT THALASSEMIA (HBT) AND SICKLE-CELL DISEASE (SCD), Clinical pharmacology and therapeutics, 55(2), 1994, pp. 175-175